Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
- Authors:
- USP affiliated authors: CASTRO, VIRGÍNIA PICANÇO E - FMRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; COVAS, DIMAS TADEU - FMRP ; PORTO, GECIÂNE SILVEIRA - FEARP
- Unidades: FMRP; FCFRP; FEARP
- DOI: 10.1080/21645515.2019.1689744
- Subjects: PATENTE; TECNOLOGIA; CÉLULAS; TESTES LABORATORIAIS; INOVAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Human Vaccines & Immunotherapeutics
- ISSN: 2164-554X
- Volume/Número/Paginação/Ano: v. 16, n. 6, p. 1424–1433, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 23 maio 2024. -
APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744 -
NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/21645515.2019.1689744 -
Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/21645515.2019.1689744 - Chimeric antigen receptor T Cells: development and production
- Chimeric antigen receptor T Cell: development and production
- Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]
- Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment
- Emerging patent landscape for non-viral vectors used for gene therapy
- CAR-T cells for cancer treatment: current design and next frontiers
- Production of recombinant coagulation factors:: are humans the best host cells?
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
- Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers
- Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems
Informações sobre o DOI: 10.1080/21645515.2019.1689744 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003067451.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
